Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HE-69 vs cyclophosphamide in refractory nephrotic syndrome
CTR20130299Phase 3Completed
- Sponsor
- Asahi Kasei Corporation
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mizoribine in nephrosis, sponsored by Asahi Kasei Corporation. Started Oct 2014; status: completed.
02
Drugs
mizoribine
03
Conditions
nephrosis
Beyond the preview
Go deeper on CTR20130299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130299.